1932

Abstract

Progress in treating and preventing mental disorders may follow from research that integrates development, genetics, and neuroscience. This review first delineates how longitudinal research has identified three particular groups of disorders shown to differ on the basis of symptom trajectories and risk-factor profiles. In the next section, the review describes how research on genetic contributions to psychopathology has elucidated the nature of risk for two groups of disorders, the neurodevelopmental and psychotic disorders. In the third section, the review describes how research on environmental contributions to psychopathology has targeted early temperament, its associated perturbations in information-processing functions, and its relations to a third group of disorders, the emotional disorders. For all three groups of disorders, such integrative research has generated ideas about novel interventions. The hope is that over the coming decade such ideas will lead to novel treatments that alter the trajectory of risk in developmental psychopathology.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-psych-010814-015038
2015-01-03
2024-06-21
Loading full text...

Full text loading...

/deliver/fulltext/psych/66/1/annurev-psych-010814-015038.html?itemId=/content/journals/10.1146/annurev-psych-010814-015038&mimeType=html&fmt=ahah

Literature Cited

  1. Alexopoulos GS, Kelly RE. 2009. Research advances in geriatric depression. World Psychiatry 8:140–49 [Google Scholar]
  2. Am. Psychiatr. Assoc 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ, 5th ed.. [Google Scholar]
  3. Angold A, Costello EJ, Erkanli A, Worthman CM. 1999. Pubertal changes in hormone levels and depression in girls. Psychol. Med. 29:1043–53 [Google Scholar]
  4. Auerbach BD, Osterweil EK, Bear MF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63–68 [Google Scholar]
  5. Bacanu SA, Kendler KS. 2013. Extracting actionable information from genome scans. Genet. Epidemiol. 37:48–59 [Google Scholar]
  6. Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van IJzendoorn MH. 2007. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol. Bull. 133:1–24 [Google Scholar]
  7. Barker TV, Reeb-Sutherland BC, Fox NA. 2014. Individual differences in fear potentiated startle in behaviorally inhibited children. Dev. Psychobiol. 56:133–41 [Google Scholar]
  8. Beard C, Sawyer AT, Hofmann SG. 2012. Efficacy of attention bias modification using threat and appetitive stimuli: a meta-analytic review. Behav. Ther. 43:724–40 [Google Scholar]
  9. Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943–61 [Google Scholar]
  10. Blair J, Mithcell D, Blair K. 2005. The Psychopath: Emotion and the Brain Oxford, UK: Blackwell Publ. [Google Scholar]
  11. Bouton ME. 2002. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol. Psychiatry 52:976–86 [Google Scholar]
  12. Britton JC, Bar-Haim Y, Clementi MA, Sankin LS, Chen G. et al. 2013a. Training-associated changes and stability of attention bias in youth: implications for attention bias modification treatment for pediatric anxiety. Dev. Cogn. Neurosci. 4:52–64 [Google Scholar]
  13. Britton JC, Grillon C, Lissek S, Norcross MA, Szuhany KL. et al. 2013b. Response to learned threat: an fMRI study in adolescent and adult anxiety. Am. J. Psychiatry 170:1195–204 [Google Scholar]
  14. Carter CS, Barch DM. 2007. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr. Bull. 33:1131–37 [Google Scholar]
  15. Carter CS, Barch DM. 2012. Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: biomarkers recommended for further development. Schizophr. Bull. 38:26–33 [Google Scholar]
  16. Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW. et al. 2011. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol. Psychiatry 70:7–12 [Google Scholar]
  17. Casey BJ, Pattwell SS, Glatt CE, Lee FS. 2013. Treating the developing brain: implications from human imaging and mouse genetics. Annu. Rev. Med. 64:427–39 [Google Scholar]
  18. Castellanos FX, Tannock R. 2002. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3:617–28 [Google Scholar]
  19. Church SM, Cotter D, Bramon E, Murray RM. 2002. Does schizophrenia result from developmental or degenerative processes?. J. Neural Transm. Suppl. 63:129–47 [Google Scholar]
  20. Cicchetti D. 2014. Illustrative developmental psychopathology perspectives on precursors and pathways to personality disorder: commentary on the special issue. J. Personal. Disord. 28:172–79 [Google Scholar]
  21. Clauss JA, Blackford JU. 2012. Behavioral inhibition and risk for developing social anxiety disorder: a meta-analytic study. J. Am. Acad. Child Adolesc. Psychiatry 51:1066–75.e1 [Google Scholar]
  22. Coe BP, Girirajan S, Eichler EE. 2012. The genetic variability and commonality of neurodevelopmental disease. Am. J. Med. Genet. C Semin. Med. Genet. 160C:118–29 [Google Scholar]
  23. Collins PY, Patel V, Joestl SS, March D, Insel TR. et al. 2011. Grand challenges in global mental health. Nature 475:27–30 [Google Scholar]
  24. Copeland WE, Shanahan L, Costello EJ, Angold A. 2009. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch. Gen. Psychiatry 66:764–72 [Google Scholar]
  25. Costello EJ, Egger HL, Angold A. 2005. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc. Psychiatr. Clin. N. Am. 14:631–48, vii [Google Scholar]
  26. Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM. et al. 2002. Development and natural history of mood disorders. Biol. Psychiatry 52:529–42 [Google Scholar]
  27. Craske MG, Wolitzky-Taylor KB, Mineka S, Zinbarg R, Waters AM. et al. 2012. Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: evidence from a longitudinal investigation. J. Abnorm. Psychol. 121:315–24 [Google Scholar]
  28. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF. 2010. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am. J. Psychiatry 167:545–54 [Google Scholar]
  29. Fox NA, Henderson HA, Marshall PJ, Nichols KE, Ghera MM. 2005. Behavioral inhibition: linking biology and behavior within a developmental framework. Annu. Rev. Psychol. 56:235–62 [Google Scholar]
  30. Gejman PV, Sanders AR, Kendler KS. 2011. Genetics of schizophrenia: new findings and challenges. Annu. Rev. Genomics Hum. Genet. 12:121–44 [Google Scholar]
  31. Graham BM, Milad MR. 2011. The study of fear extinction: implications for anxiety disorders. Am. J. Psychiatry 168:415–23 [Google Scholar]
  32. Grillon C, Warner V, Hille J, Merikangas KR, Bruder GE. et al. 2005. Families at high and low risk for depression: a three-generation startle study. Biol. Psychiatry 57:953–60 [Google Scholar]
  33. Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA. et al. 2010. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol. Psychiatry 68:982–90 [Google Scholar]
  34. Han K, Holder JL Jr, Schaaf CP, Lu H, Chen H. et al. 2013. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503:72–77 [Google Scholar]
  35. Harvey PD, Heaton RK, Carpenter WT. Green MF, Gold JM, Schoenbaum M. Jr, 2012. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophr. Res. 140:9–14 [Google Scholar]
  36. Hayward C, Sanborn K. 2002. Puberty and the emergence of gender differences in psychopathology. J. Adolesc. Health 30:49–58 [Google Scholar]
  37. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158:1568–78 [Google Scholar]
  38. Hoeft F, Lightbody AA, Hazlett HC, Patnaik S, Piven J, Reiss AL. 2008. Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. Arch. Gen. Psychiatry 65:1087–97 [Google Scholar]
  39. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS. et al. 2010. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167:748–51 [Google Scholar]
  40. Insel TR. 2009. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch. Gen. Psychiatry 66:128–33 [Google Scholar]
  41. Jaeggi SM, Buschkuehl M, Shah P, Jonides J. 2014. The role of individual differences in cognitive training and transfer. Mem. Cogn. 42:464–80 [Google Scholar]
  42. Jarcho JM, Fox NA, Pine DS, Etkin A, Leibenluft E. et al. 2013. The neural correlates of emotion-based cognitive control in adults with early childhood behavioral inhibition. Biol. Psychol. 92:306–14 [Google Scholar]
  43. Jonas RK, Montojo CA, Bearden CE. 2014. The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol. Psychiatry 75:351–60 [Google Scholar]
  44. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:593–602 [Google Scholar]
  45. Klin A, Jones W, Schultz R, Volkmar F, Cohen D. 2002. Defining and quantifying the social phenotype in autism. Am. J. Psychiatry 159:895–908 [Google Scholar]
  46. Klin A, Lin DJ, Gorrindo P, Ramsay G, Jones W. 2009. Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature 459:257–61 [Google Scholar]
  47. Kotov R, Leong SH, Mojtabai R, Erlanger AC, Fochtmann LJ. et al. 2013. Boundaries of schizoaffective disorder: revisiting Kraepelin. JAMA Psychiatry 70:1276–86 [Google Scholar]
  48. Lahat A, Lamm C, Chronis-Tuscano A, Pine DS, Henderson HA, Fox NA. 2014. Early behavioral inhibition and increased error monitoring predict later social phobia symptoms in childhood. J. Am. Acad. Child Adolesc. Psychiatry 53:447–55 [Google Scholar]
  49. LaSalle JM, Powell WT, Yasui DH. 2013. Epigenetic layers and players underlying neurodevelopment. Trends Neurosci. 36:460–70 [Google Scholar]
  50. Lau JY, Britton JC, Nelson EE, Angold A, Ernst M. et al. 2011. Distinct neural signatures of threat learning in adolescents and adults. Proc. Natl. Acad. Sci. USA 108:4500–5 [Google Scholar]
  51. Lewis-Morrarty E, Degnan KA, Chronis-Tuscano A, Rubin KH, Cheah CS. et al. 2012. Maternal over-control moderates the association between early childhood behavioral inhibition and adolescent social anxiety symptoms. J. Abnorm. Child Psychol. 40:1363–73 [Google Scholar]
  52. Lissek S, Pine DS, Grillon C. 2006. The strong situation: a potential impediment to studying the psychobiology and pharmacology of anxiety disorders. Biol. Psychol. 72:265–70 [Google Scholar]
  53. Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G. et al. 2005. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav. Res. Ther. 43:1391–424 [Google Scholar]
  54. Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M. et al. 2010. Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am. J. Psychiatry 167:47–55 [Google Scholar]
  55. Lord C, Risi S, DiLavore PS, Shulman C, Thurm A, Pickles A. 2006. Autism from 2 to 9 years of age. Arch. Gen. Psychiatry 63:694–701 [Google Scholar]
  56. McDermott JM, Perez-Edgar K, Henderson HA, Chronis-Tuscano A, Pine DS, Fox NA. 2009. A history of childhood behavioral inhibition and enhanced response monitoring in adolescence are linked to clinical anxiety. Biol. Psychiatry 65:445–48 [Google Scholar]
  57. Meaney MJ. 2001. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24:1161–92 [Google Scholar]
  58. Moffitt TE, Caspi A. 2001. Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Dev. Psychopathol. 13:355–75 [Google Scholar]
  59. Moser JS, Moran TP, Schroder HS, Donnellan MB, Yeung N. 2013. On the relationship between anxiety and error monitoring: a meta-analysis and conceptual framework. Front. Hum. Neurosci. 7:466 [Google Scholar]
  60. Murdoch JD, State MW. 2013. Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 23:310–15 [Google Scholar]
  61. Nigg JT. 2007. What Causes ADHD? New York: Guilford [Google Scholar]
  62. Nigg JT, Casey BJ. 2005. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev. Psychopathol. 17:785–806 [Google Scholar]
  63. Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. 2012. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Dev. Psychopathol. 24:529–36 [Google Scholar]
  64. Owen MJ, Craddock N, O'Donovan MC. 2010. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch. Gen. Psychiatry 67:667–73 [Google Scholar]
  65. Ozonoff S, Cook I, Coon H, Dawson G, Joseph RM. et al. 2004. Performance on Cambridge Neuropsychological Test Automated Battery subtests sensitive to frontal lobe function in people with autistic disorder: evidence from the Collaborative Programs of Excellence in Autism network. J. Autism Dev. Disord. 34:139–50 [Google Scholar]
  66. Parker KJ, Buckmaster CL, Sundlass K, Schatzberg AF, Lyons DM. 2006. Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proc. Natl. Acad. Sci. USA 103:3000–5 [Google Scholar]
  67. Pine DS, Cohen E, Cohen P, Brook J. 1999. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder?. Am. J. Psychiatry 156:133–35 [Google Scholar]
  68. Pine DS, Cohen JA. 2002. Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol. Psychiatry 51:519–31 [Google Scholar]
  69. Pine DS, Cohen P, Gurley D, Brook J, Ma Y. 1998. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch. Gen. Psychiatry 55:56–64 [Google Scholar]
  70. Pine DS, Helfinstein SM, Bar-Haim Y, Nelson E, Fox NA. 2009. Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety. Neuropsychopharmacology 34:213–28 [Google Scholar]
  71. Quirk GJ, Mueller D. 2008. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33:56–72 [Google Scholar]
  72. Rapee RM. 2013. The preventative effects of a brief, early intervention for preschool-aged children at risk for internalising: follow-up into middle adolescence. J. Child Psychol. Psychiatry 54:780–88 [Google Scholar]
  73. Reeb-Sutherland BC, Helfinstein SM, Degnan KA, Perez-Edgar K, Henderson HA. et al. 2009. Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J. Am. Acad. Child Adolesc. Psychiatry 48:610–17 [Google Scholar]
  74. Rosenbaum JF, Biederman J, Hirshfeld-Becker DR, Kagan J, Snidman N. et al. 2000. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am. J. Psychiatry 157:2002–10 [Google Scholar]
  75. Rutter M. 2002. The interplay of nature, nurture, and developmental influences: the challenge ahead for mental health. Arch. Gen. Psychiatry 59:996–1000 [Google Scholar]
  76. Rutter M. 2005. Autism research: lessons from the past and prospects for the future. J. Autism Dev. Disord. 35:241–57 [Google Scholar]
  77. Rutter M, Kim-Cohen J, Maughan B. 2006. Continuities and discontinuities in psychopathology between childhood and adult life. J. Child Psychol. Psychiatry 47:276–95 [Google Scholar]
  78. Salum GA, Mogg K, Bradley BP, Gadelha A, Pan P. et al. 2012. Threat bias in attention orienting: evidence of specificity in a large community-based study. Psychol. Med. 43:733–45 [Google Scholar]
  79. Shatz CJ. 2009. MHC class I: an unexpected role in neuronal plasticity. Neuron 64:40–45 [Google Scholar]
  80. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R. et al. 2013. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503:267–71 [Google Scholar]
  81. Shechner T, Britton JC, Perez-Edgar K, Bar-Haim Y, Ernst M. et al. 2012. Attention biases, anxiety, and development: toward or away from threats or rewards?. Depress. Anxiety 29:282–94 [Google Scholar]
  82. Shechner T, Rimon-Chakir A, Britton JC, Lotan D, Apter A. et al. 2014. Attention bias modification treatment augmenting effects on cognitive behavioral therapy in children with anxiety: randomized controlled trial. J. Am. Acad. Child Adolesc. Psychiatry 53:61–71 [Google Scholar]
  83. State MW, Levitt P. 2011. The conundrums of understanding genetic risks for autism spectrum disorders. Nat. Neurosci. 14:1499–506 [Google Scholar]
  84. State MW, Sestan N. 2012. Neuroscience. The emerging biology of autism spectrum disorders. Science 337:1301–3 [Google Scholar]
  85. Torpey DC, Hajcak G, Kim J, Kujawa AJ, Dyson MW. et al. 2013. Error-related brain activity in young children: associations with parental anxiety and child temperamental negative emotionality. J. Child Psychol. Psychiatry 54:854–62 [Google Scholar]
  86. Van Bockstaele B, Verschuere B, Tibboel H, De Houwer J, Crombez G, Koster EH. 2013. A review of current evidence for the causal impact of attentional bias on fear and anxiety. Psychol. Bull. 140:682–721 [Google Scholar]
  87. van der Werf M, Hanssen M, Kohler S, Verkaaik M, Verhey FR. et al. 2014. Systematic review and collaborative recalculation of 133,693 incident cases of schizophrenia. Psychol. Med. 44:9–16 [Google Scholar]
  88. van Os J. 2013. The dynamics of subthreshold psychopathology: implications for diagnosis and treatment. Am. J. Psychiatry 170:695–98 [Google Scholar]
  89. van Os J, Kenis G, Rutten BP. 2010. The environment and schizophrenia. Nature 468:203–12 [Google Scholar]
  90. Veenstra-VanderWeele J, Blakely RD. 2012. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology 37:196–212 [Google Scholar]
  91. Wald I, Degnan KA, Gorodetsky E, Charney DS, Fox NA. et al. 2013. Attention to threats and combat-related posttraumatic stress symptoms: prospective associations and moderation by the serotonin transporter gene. JAMA Psychiatry 70:401–8 [Google Scholar]
  92. Walters JT, Rujescu D, Franke B, Giegling I, Vasquez AA. et al. 2013. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am. J. Psychiatry 170:877–85 [Google Scholar]
  93. Wilson M. 1993. DSM-III and the transformation of American psychiatry: a history. Am. J. Psychiatry 150:399–410 [Google Scholar]
  94. Wolff JJ, Gu H, Gerig G, Elison JT, Styner M. et al. 2012. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am. J. Psychiatry 169:589–600 [Google Scholar]
/content/journals/10.1146/annurev-psych-010814-015038
Loading
/content/journals/10.1146/annurev-psych-010814-015038
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error